Tempus AI (NASDAQ:TEM) Earns Buy Rating from Analysts at Bank of America

Bank of America started coverage on shares of Tempus AI (NASDAQ:TEM) in a research report sent to investors on Tuesday morning, MarketBeat.com reports. The firm issued a buy rating and a $41.00 price objective on the stock.

A number of other brokerages have also recently commented on TEM. Needham & Company LLC assumed coverage on Tempus AI in a research report on Tuesday. They issued a buy rating and a $47.00 price target for the company. Longbow Research assumed coverage on shares of Tempus AI in a report on Tuesday. They issued a buy rating and a $48.00 target price for the company. William Blair initiated coverage on shares of Tempus AI in a report on Tuesday. They set an outperform rating on the stock. JPMorgan Chase & Co. assumed coverage on shares of Tempus AI in a research note on Tuesday. They issued an overweight rating and a $42.00 price objective for the company. Finally, Loop Capital started coverage on shares of Tempus AI in a research note on Tuesday. They set a buy rating and a $48.00 target price on the stock. Nine research analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the stock presently has an average rating of Buy and an average price target of $45.63.

Tempus AI Price Performance

Shares of TEM opened at $37.50 on Tuesday. Tempus AI has a 1-year low of $22.89 and a 1-year high of $43.88.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.